References
Anderson RM (1997) “Conclusions — scientific research and its implications.” In: Zeki S (ed.) Human genetics — uncertainties and the financial implications ahead. Philos Trans R Soc Lond B Biol Sci 352:1107–1110
Andrews LB, Fullarton JE,Holtzman NA, Motulsky AG (eds.) (1994) “Assessing genetic risks. Implications for health and social policy.” Washington: National Academy
Bodmer WF (1997) “Genetic diversity and disease susceptibility.” In: Zeki S (ed) Human genetics — uncertainties and the financial implications ahead. Philos Trans R Soc Lond B Biol Sci 352:1045–1050
Cairns J, Shackley P (1993) “Sometimes sensitive, seldom specific: a review of the economics of screening.” Health Econ 2:43–53
Elias S, Annas GL, Simpson JL (1992) “Carrier screening for cystic fibrosis: a case study in setting standards of medical practice.” In: Annas GJ, Elias S (eds) Gene mapping.Using law and ethics as guides.Oxford: Oxford University Press,pp 186–202
Holland WW, Stewart S (1990) “Screening in health care: benefit or bane?” London: Nuffield Provincial Hospitals Trust
MacIntyre S (1997) “Social and psychological issues associated with the new genetics.” In: Zeki S (ed) Human genetics — uncertainties and the financial implications ahead. Philos Trans R Soc Lond B Biol Sci 352:1095–1101
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schöffski, O. Genetic testing and the health care system. Eur J Health Econom 3, 73–76 (2002). https://doi.org/10.1007/s10198-002-0106-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-002-0106-9